Bermudez, Tadeo
Sammani, Saad
Song, Jin H.
Hernon, Vivian Reyes
Kempf, Carrie L.
Garcia, Alexander N.
Burt, Jessica
Hufford, Matthew
Camp, Sara M.
Cress, Anne E.
Desai, Ankit A.
Natarajan, Viswanathan
Jacobson, Jeffrey R.
Dudek, Steven M.
Cancio, Leopoldo C.
Alvarez, Julie
Rafikov, Ruslan
Li, Yansong
Zhang, Donna D.
Casanova, Nancy G.
Bime, Christian
Garcia, Joe G. N.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K08 HL141623)
National Heart, Lung, and Blood Institute (P01 HL126609)
Article History
Received: 4 May 2021
Accepted: 22 December 2021
First Online: 13 January 2022
Competing interests
: Joe GN Garcia MD is CEO and founder of Aqualung Therapeutics Corporation. All other authors declare no competing financial interests.